Skip to main content
Equibles

Josh Jennings

Analyst

Cowen

Equibles does not estimate personal net worth.

About Josh Jennings

Josh Jennings is recorded as Analyst at Cowen. Josh Jennings has spoken on 3 earnings calls across 3 companies, most recently for Zimmer Biomet Holdings, Inc. on February 7, 2022. Those appearances were for Zimmer Biomet Holdings, Inc. (ZBH), Becton Dickinson & Co (BDX) and Johnson & Johnson (JNJ). The companies whose calls Josh Jennings spoke on are classified in the Healthcare sector.

Josh Jennings on recent calls

“I wanted to start with 2022 revenue guidance and make sure I understand the impact of VBP that you are baking into the range.”
Analyst — Cowen, Zimmer Biomet Holdings, Inc. Q4 FY2021 Earnings Call ·
“Just one question on Alaris and one follow-up. On Alaris, a lot of focus there some great updates by the Becton team today. I was just wondering if you could help us understand, how much of a drag the Alaris mediation has been on the core business's organic revenue growth?”
Analyst — Cowen, Becton Dickinson & Co Q2 FY2021 Earnings Call ·
“I had a follow-up to Bob's question just on the vaccine and how revenues and expenses flow through the P&L. Just wanted to sanity check the 100 million doses by mid-year in the U.S., 100 million more by the end of 2021, and 200 million doses in Europe.”
Analyst — Cowen, Johnson & Johnson Q1 FY2021 Earnings Call ·

Affiliation history

  • Cowen

    Analyst

    Source not stated

    Current

Company network

Recent activity